Teneligliptin D8 is the octa-deuterated form of Teneligliptin (MP-513; trade name Tenelia in Japan) is an orally bioavailable and long-lasting dipeptidyl peptidase-4 (DPP-4) inhibitor approved for the treatment of type 2 diabetes mellitus.

纯度：≥98%

CAS：1391012-95-5